Ignite Creation Date:
2025-12-24 @ 12:57 PM
Ignite Modification Date:
2026-01-15 @ 12:52 AM
Study NCT ID:
NCT04941261
Status:
UNKNOWN
Last Update Posted:
2022-10-28
First Post:
2021-06-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha)
Sponsor:
National Vaccine and Serum Institute, China
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-18
First Submit QC Date:
None
Study First Post Date:
2021-06-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-26
Last Update Post Date:
2022-10-28
Last Update Post Date Type:
ACTUAL